<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2648">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04682093</url>
  </required_header>
  <id_info>
    <org_study_id>123456</org_study_id>
    <nct_id>NCT04682093</nct_id>
  </id_info>
  <brief_title>Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED</brief_title>
  <acronym>EUROCOV</acronym>
  <official_title>Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED (EUROCOV Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Society for Emergency Medicine (EUSEM) Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>European Society for Emergency Medicine (EUSEM) Research Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is an unfunded collaboration of approximately 30 emergency departments across&#xD;
      Europe led by the EUSEM research network. It involves collection of data in relation to&#xD;
      determining the epidemiology and outcome of adult patients who present to emergency&#xD;
      departments with a suspected Covid infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the past 6 months, the world has faced a novel infection disease outbreak, due to a&#xD;
      novel coronavirus, the severe acute respiratory syndrome coronavirus (SARS-CoV2), with a&#xD;
      massive impact on healthcare resource.&#xD;
&#xD;
      In Europe, numbers of confirmed cases continue to rise. Europe is currently one of the&#xD;
      regions with the highest number of Covid-19 cases and deaths due to this emergent diseases.&#xD;
&#xD;
      Most COVID-19 infected patients present with mild to moderate acute respiratory symptoms,&#xD;
      including cough, fever, dyspnea and pneumonia. About 20% will present with severe or critical&#xD;
      manifestations of the disease, including pneumonia, respiratory failure and acute respiratory&#xD;
      distress syndrome (ARDS).&#xD;
&#xD;
      Anticipating the needs for hospitalization in ward and/or intensive care is crucial.&#xD;
&#xD;
      Emergency departments are at the front line for triaging patients with suspected Covid-19 and&#xD;
      referring them to the appropriate level of care.&#xD;
&#xD;
      In Europe, the number of ED patients with suspected Covid-19 is variable; rate of&#xD;
      hospitalization from ED reaches 40% for this population.&#xD;
&#xD;
      Risk stratification and management decisions of patients presenting to the ED with suspected&#xD;
      COVID-19 is a challenge for emergency physicians.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>hospitalization</measure>
    <time_frame>30 days</time_frame>
    <description>hospitalization after ED visit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Hospital LOS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death during hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU admission</measure>
    <time_frame>30 days</time_frame>
    <description>ICU admission after ED visit</description>
  </primary_outcome>
  <enrollment type="Anticipated">8000</enrollment>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        - Adult patients (&gt;= 18 years old) attending the ED with a clinical suspicion of COVID-19&#xD;
        based on the presence of the following criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (&gt;= 18 years old) attending the ED with a clinical suspicion of&#xD;
             COVID-19 based on the presence of the following criteria&#xD;
&#xD;
          -  Fever &gt;= 38 °C&#xD;
&#xD;
          -  respiratory symptoms (dyspnea, cough, expectorations)&#xD;
&#xD;
          -  any other symptoms suggestive of COVID-19 including digestive signs (diarrhea,&#xD;
             anosmia…)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>130 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Said LARIBI, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EUSEM Research network chair</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>EUSEM RN Country lead</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EUSEM RN Country lead</name>
      <address>
        <city>Hämeenlinna</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EUSEM RN Country lead</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EUSEM RN Country lead</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EUSEM RN Country lead</name>
      <address>
        <city>Forlì</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Greece</country>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
  </removed_countries>
  <reference>
    <citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.</citation>
    <PMID>32091533</PMID>
  </reference>
  <reference>
    <citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.</citation>
    <PMID>32171076</PMID>
  </reference>
  <reference>
    <citation>Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.</citation>
    <PMID>32167524</PMID>
  </reference>
  <reference>
    <citation>Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, Lau SK, Anderson DE, Chan KS, Tan TY, Ng TY, Cui L, Said Z, Kurupatham L, Chen MI, Chan M, Vasoo S, Wang LF, Tan BH, Lin RTP, Lee VJM, Leo YS, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204. Erratum in: JAMA. 2020 Apr 21;323(15):1510.</citation>
    <PMID>32125362</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 23, 2020</last_update_submitted>
  <last_update_submitted_qc>December 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Covid19</keyword>
  <keyword>Emergencies</keyword>
  <keyword>epidemiology</keyword>
  <keyword>prognosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

